Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

COVID-19 Update: Vaccine No. 4 and the CDC’s Quarantine and Isolation Calculator

By Yvonne Puig (US), Daphne Calderon (US) & Hannah Putnam (US) on March 30, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

Yesterday, March 29, 2022, the CDC launched a new calculator designed to help individuals exposed to COVID-19 discern how many days of quarantine and/or isolation are necessary. This tool was created in order to aid in the prevention of spreading the virus.

Users are first prompted to select whether they have tested positive for COVID-19 or whether they had close contact with someone who had COVID-19. From there, if the user has tested positive, the user answers whether they have symptoms. If the user has symptoms, the calculator asks about specific types of symptoms and after working through the question prompts in the calculator, they are given a date when he or she can safely leave the home. The process is the same for users who do not have COVID-19 but were exposed to someone who was infected. Likewise, the results are contingent on the answers and yield a date when it is safe for that individual to leave their home.

Additionally, the CDC recommended an additional booster shot—the fourth round—for certain classifications of individuals. This recommendation came after the FDA gave authorization for this fourth round for older and immunocompromised individuals. Only Pfizer and Moderna are approved for a second booster.

The individuals eligible for this additional vaccination are those over 50 years old and who received their last booster at least four months prior. For Pfizer specifically, individuals over 12 years of age who have compromised immune systems are also eligible for a second booster if at least four months have elapsed since the administration of their first booster shot.  For Moderna, individuals over the age of 18 who have compromised immune systems are eligible for a second booster if at least four months have elapsed since the administration of their first booster shot.

Norton Rose Fulbright lawyers will continue to provide relevant updates for healthcare providers on the Health Law Pulse during the COVID-19 public health crisis.

Photo of Yvonne Puig (US) Yvonne Puig (US)

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in…

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in Norton Rose Fulbright’s Austin office, Yvonne’s practice involves commercial and health care litigation, antitrust, regulatory and compliance advice, crisis management, staff privileges, exclusive contracting and administrative law.

Read more about Yvonne Puig (US)Email
Show more Show less
Photo of Daphne Calderon (US) Daphne Calderon (US)
Read more about Daphne Calderon (US)Email
Photo of Hannah Putnam (US) Hannah Putnam (US)
Read more about Hannah Putnam (US)Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo